chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Pain in extremity
Clinical narrative: Severe pain of the left arm; left chest pain; Severe pain of the left arm; left chest pain; This is a spontaneous report received from a non-contactable consumer or other non hcp.A 56 years old adult male patient received 2nd dose of bnt162b2 (COMIRNATY,Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 04Apr2021 10:00,at the age of 56 years old, as Dose 2,single for covid-19 immunization.The patient medical history was not reported.There were no concomitant medications.The patient experienced severe pain of the left arm; left chest pain on 04Apr2021 02:00.The outcome of the events was recovering.The patient previously received his 1st dose of Pfizer covid vaccine on 14Mar2021,01:45 PM.The patient was not diagnosed with covid prior vaccination and not tested post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chest discomfort, Decreased appetite, Dyspnoea, Lethargy
Clinical narrative: 101 plus temp; heaviness in chest; difficulty breathing deeply; severe itchy rash/welts on torso, entire back, legs and arms; achy; lethargic; no appetite; This is a spontaneous report from a contactable consumer.   A 54-years-old not-pregnant female patient received (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection), dose 1 via an unspecified route of administration, administered in right arm on 24Apr2021 at 11:00 AM (Batch/Lot number: unknown) (age at vaccination 54-years) as dose 1, single for covid-19 immunisation. The patient had possibly of penicillin allergy. Medical history included breast cancer from an unknown date to 2021 (breast cancer 5 years ago, currently recovered). The patient was not pregnant. The patient had not received any other vaccine within 4 weeks. Patient had not been tested post the vaccination. Concomitant medications included vitamin d nos (VITAMIN D NOS); biotin (BIOTIN) both taken for an unspecified indication, start and stop date were not reported and multi vitamin. The patient experienced 101 plus temp, heaviness in chest, difficulty breathing deeply, severe itchy rash/welts on torso, entire back, legs and arms, achy, lethargic, no appetite on 26 Apr2021 at 06:00 PM. Adverse event resulted in patient visited to Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included body temperature 101 plus temperature on 26Apr2021. The therapeutic measure was taken with steroid, inhaler. The outcome of all events was recovering.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Rash pruritic
Clinical narrative: 101 plus temp; heaviness in chest; difficulty breathing deeply; severe itchy rash/welts on torso, entire back, legs and arms; achy; lethargic; no appetite; This is a spontaneous report from a contactable consumer.   A 54-years-old not-pregnant female patient received (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection), dose 1 via an unspecified route of administration, administered in right arm on 24Apr2021 at 11:00 AM (Batch/Lot number: unknown) (age at vaccination 54-years) as dose 1, single for covid-19 immunisation. The patient had possibly of penicillin allergy. Medical history included breast cancer from an unknown date to 2021 (breast cancer 5 years ago, currently recovered). The patient was not pregnant. The patient had not received any other vaccine within 4 weeks. Patient had not been tested post the vaccination. Concomitant medications included vitamin d nos (VITAMIN D NOS); biotin (BIOTIN) both taken for an unspecified indication, start and stop date were not reported and multi vitamin. The patient experienced 101 plus temp, heaviness in chest, difficulty breathing deeply, severe itchy rash/welts on torso, entire back, legs and arms, achy, lethargic, no appetite on 26 Apr2021 at 06:00 PM. Adverse event resulted in patient visited to Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included body temperature 101 plus temperature on 26Apr2021. The therapeutic measure was taken with steroid, inhaler. The outcome of all events was recovering.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles on face; This is a spontaneous report from a non-contactable consumer or other non hcp(patient).  A 25-years-old male patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: Unknown), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced shingles on face on an unspecified date. No, covid prior vaccination, No, covid tested post vaccination. Outcome of the event was unknown.   Device timestamp: 28/Apr/2021  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Fatigue, Herpes zoster, Loss of personal independence in daily activities, Migraine
Clinical narrative: Shingles; I had a small rash or irritation inside right armpit.; Achy; Fatigued; Migraine like symptoms; Became more painful; Condition worsened; Still not up to working or physical activity; This is a spontaneous report from a contactable consumer (patient). A 55-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0150, patient was 55-year-old at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 04Apr2021 at 09:30 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included degenerated discs L4-L5, L5-S-1, neuropathy (feet), anxiety, depression, Benign prostatic hyperplasia, high cholesterol, Known allergies: penicillin. Concomitant medication(s) included alfuzosin (ALFUZOSIN); atorvastatin (ATORVASTATIN); bupropion (BUPROPION); clomiphene citrate (CLOMIPHENE CITRATE) all were taken for an unspecified indication in two weeks of vaccination, start and stop date were not reported. The patient previously took amoxicillin and experienced allergies. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EN6208), via an unspecified route of administration, administered in Arm Left on 04Apr2021 at 09:30 as DOSE 1, SINGLE for covid-19 immunisation and experienced pain and fatigue. No other vaccine received in four weeks. It was reported that similar to first dose, started feeling achy and fatigued, around 48 hours after receiving second dose. On the 4th day, had a small rash or irritation inside right armpit. That spread to chest by day 5 and suspected shingles. On day 6 had a video appt with a doctor who confirmed shingles and prescribed Valtrax, which took twice daily for 7 days. The condition worsened and became more painful, and developed migraine like symptoms for several days. Today day 23 of feeling these ill effects, had some improvement but am still not up to working or physical activity. No Covid prior vaccination, no Covid tested post vaccination. On 08Apr2021, the patient experienced i had a small rash or irritation inside right armpit, on 09Apr2021, the patient experienced shingles, on 06Apr2021, the patient experienced achy, fatigued at 18:00 with outcome of recovering, on an unspecified date in Apr2021, the patient experienced migraine like symptoms, became more painful, condition worsened, still not up to working or physical activity. AE resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken for all reported events with Valtrax. The outcomes of all reported events were recovering.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Rash
Clinical narrative: Shingles; I had a small rash or irritation inside right armpit.; Achy; Fatigued; Migraine like symptoms; Became more painful; Condition worsened; Still not up to working or physical activity; This is a spontaneous report from a contactable consumer (patient). A 55-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0150, patient was 55-year-old at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 04Apr2021 at 09:30 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included degenerated discs L4-L5, L5-S-1, neuropathy (feet), anxiety, depression, Benign prostatic hyperplasia, high cholesterol, Known allergies: penicillin. Concomitant medication(s) included alfuzosin (ALFUZOSIN); atorvastatin (ATORVASTATIN); bupropion (BUPROPION); clomiphene citrate (CLOMIPHENE CITRATE) all were taken for an unspecified indication in two weeks of vaccination, start and stop date were not reported. The patient previously took amoxicillin and experienced allergies. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EN6208), via an unspecified route of administration, administered in Arm Left on 04Apr2021 at 09:30 as DOSE 1, SINGLE for covid-19 immunisation and experienced pain and fatigue. No other vaccine received in four weeks. It was reported that similar to first dose, started feeling achy and fatigued, around 48 hours after receiving second dose. On the 4th day, had a small rash or irritation inside right armpit. That spread to chest by day 5 and suspected shingles. On day 6 had a video appt with a doctor who confirmed shingles and prescribed Valtrax, which took twice daily for 7 days. The condition worsened and became more painful, and developed migraine like symptoms for several days. Today day 23 of feeling these ill effects, had some improvement but am still not up to working or physical activity. No Covid prior vaccination, no Covid tested post vaccination. On 08Apr2021, the patient experienced i had a small rash or irritation inside right armpit, on 09Apr2021, the patient experienced shingles, on 06Apr2021, the patient experienced achy, fatigued at 18:00 with outcome of recovering, on an unspecified date in Apr2021, the patient experienced migraine like symptoms, became more painful, condition worsened, still not up to working or physical activity. AE resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken for all reported events with Valtrax. The outcomes of all reported events were recovering.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: developed shingles; This is a spontaneous report from a contactable Other HCP (patient). A 68-years-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 11Apr2021 at 15:15 (at the age of 67-years) as dose number unknown, single in the left arm for covid-19 immunisation. The patient medical history she just was diagnosed, no yet treated for shingles. Had chicken pox in 1953. The patient had known allergies to Bactrim, Cipro. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Apr2021, the patient experienced developed shingles. Patient visited to doctor or other healthcare professional office/clinic visit. Patient received treatment for event with antiviral. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Herpes zoster, Lymphadenopathy, Pyrexia
Clinical narrative: Lymph node under left arm became swollen; shingles; Fever; Chills; Headache; This is a spontaneous report from a contactable Consumer (patient herself). A 54-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 23Apr2021 at 04:45 (at the age of 54-years-old) as a DOSE 1, SINGLE for covid-19 immunisation at the age of School or Student Health Clinic. The patient medical history included hypertension (High blood pressure) and anxiety both from an unknown date and unknown if ongoing. Concomitant medications included lisinopril (LISINOPRIL) and escitalopram oxalate (LEXAPRO) both were taken for an unspecified indication, start and stop date were not reported. The patient had no known allergies. The patient did not receive other vaccine in four weeks. It was unknown if patient had covid prior vaccination. The patient was not tested for covid post vaccination. On 25Mar2021 at 04:45, the patient experienced lymph node under left arm became swollen, shingles, fever, chills and headache. The patient reported that, one week after 1st does broke out with shingles. Event resulted in the Doctor or other healthcare professional office/clinic visit. Treatment was received with Anti-viral medication. Outcome of all the events were recovering.  The lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Coagulopathy, Dysmenorrhoea, Heavy menstrual bleeding
Clinical narrative: very painful cramping; Very heavy menstrual flow/large quantity clotting; Very heavy menstrual flow/large quantity clotting; This is a spontaneous report from a contactable other hcp (patient). A 42-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: En6206) via an unspecified route of administration, administered in arm left on 09Mar2021 14:15 (at the age of 42-year-old) as dose 1, single and received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Er8734) via an unspecified route of administration, administered in arm left on 30Mar2021 at dose 2, single for Covid-19 immunization. Medical history included Graves' disease from an unknown date and unknown if ongoing, total thyroidectomy from 2010 to an unknown date, known allergies: Pineapples. Patient did not have other vaccine in four weeks. Patient did not have covid prior vaccination. Patient was not tested for covid post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID 150); collagen (COLLAGEN); multivitamins [vitamins nos] (MULTIVITAMINS [VITAMINS NOS]) all taken for an unspecified indication, start and stop date were not reported (Other medications in two weeks). On 03Apr2021 07:00 the patient experienced very painful cramping, very heavy menstrual flow/large quantity clotting. Patient did not receive treatment for the adverse events. Outcome of the events was resolved on an unspecified date in 2021. No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Varicella
Clinical narrative: Chicken Pox; fevers; This is a spontaneous report from a contactable consumer (patient's wife). A male patient (reporter's husband) of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6203) via an unspecified route of administration in left arm on 03Mar2021 at 10:30 as single dose for COVID-19 immunization. Medical history, concomitant medications or past drug history of the patient were not reported. On an unspecified in 2021, patient experienced chicken Pox, and was totally covered from head to toe, had fever and missed 3 weeks of work. Outcome of the events were unknown.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Coagulopathy, Contusion
Clinical narrative: Clotting issue; My legs are covered in bruises; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown), via an unspecified route of administration on 21Apr2021 10:15 (at the age of 35-year-old) as dose number unknown, single for COVID-19 immunization. Medical history included known allergies: Tree nuts from an unknown date and unknown if ongoing. Concomitant medication(s) included clarithromycin (CLARITIN [CLARITHROMYCIN]) taken for allergies, start and stop date were not reported (other medications the patient received within 2 weeks of vaccination). The patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Reported that It was now the 23rd and I took my pants off at the end of the day and my legs are covered in bruises (22Apr2021). There was inadequate data online pertaining to this reaction and I was concerned it was due to the clotting issue (22Apr2021). There was no treatment for the events. The clinical outcome of events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Chest pain, Diarrhoea, Dizziness
Clinical narrative: dizzy; weak; same day- moderate arm pain radiating to chest and back/Next day- 5:30 am awakened by severe arm/back/chest pain; twitching; eye/headache; eye/headache; high fever; sweating; nausea/diarrhea; nausea/diarrhea; swollen glands; sore throat; whole body ache; same day- moderate arm pain radiating to chest and back/Next day- 5:30 am awakened by severe arm/back/chest pain; same day- moderate arm pain radiating to chest and back/Next day- 5:30 am awakened by severe arm/back/chest pain; This is a spontaneous report from a contactable consumer (patient). A 30-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Er8731), dose 2 via an unspecified route of administration, administered in Arm Right on 25Apr2021 at 11:15 (at the age of 30-years-old) as dose 2, single for covid-19 immunisation. Medical history included allergic to cherries. Concomitant medication included minocycline. The patient previously took bnt162b2 (Batch/Lot Number: Ew0150) as first dose on 04Apr2021 at 11:15 (at the age of 30-years-old) for covid-19 immunisation and experienced Arm pain and severe headache; ceclor and experienced allergy. On 25Apr2021, the patient experienced "same day- moderate arm pain radiating to chest and back/next day- 5:30 am awakened by severe arm/back/chest pain, on 26Apr2021 at 05:30 same day- moderate arm pain radiating to chest and back/next day- 5:30 am awakened by severe arm/back/chest pain (back pain), twitching, eye/headache, high fever, sweating, nausea/diarrhea, swollen glands, sore throat, whole body ache and dizzy on 28Apr2021, weak on 28Apr2021. other vaccine same date vaccine date was provided as 25Apr2021. Facility type vaccine was military base. The patient received no other vaccine in four weeks. Treatment was provided for the events. The patient was not COVID prior vaccination and did not test for COVID post vaccination. Outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Headache, Hyperhidrosis, Lymphadenopathy, Muscle twitching
Clinical narrative: dizzy; weak; same day- moderate arm pain radiating to chest and back/Next day- 5:30 am awakened by severe arm/back/chest pain; twitching; eye/headache; eye/headache; high fever; sweating; nausea/diarrhea; nausea/diarrhea; swollen glands; sore throat; whole body ache; same day- moderate arm pain radiating to chest and back/Next day- 5:30 am awakened by severe arm/back/chest pain; same day- moderate arm pain radiating to chest and back/Next day- 5:30 am awakened by severe arm/back/chest pain; This is a spontaneous report from a contactable consumer (patient). A 30-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Er8731), dose 2 via an unspecified route of administration, administered in Arm Right on 25Apr2021 at 11:15 (at the age of 30-years-old) as dose 2, single for covid-19 immunisation. Medical history included allergic to cherries. Concomitant medication included minocycline. The patient previously took bnt162b2 (Batch/Lot Number: Ew0150) as first dose on 04Apr2021 at 11:15 (at the age of 30-years-old) for covid-19 immunisation and experienced Arm pain and severe headache; ceclor and experienced allergy. On 25Apr2021, the patient experienced "same day- moderate arm pain radiating to chest and back/next day- 5:30 am awakened by severe arm/back/chest pain, on 26Apr2021 at 05:30 same day- moderate arm pain radiating to chest and back/next day- 5:30 am awakened by severe arm/back/chest pain (back pain), twitching, eye/headache, high fever, sweating, nausea/diarrhea, swollen glands, sore throat, whole body ache and dizzy on 28Apr2021, weak on 28Apr2021. other vaccine same date vaccine date was provided as 25Apr2021. Facility type vaccine was military base. The patient received no other vaccine in four weeks. Treatment was provided for the events. The patient was not COVID prior vaccination and did not test for COVID post vaccination. Outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, Pain, Pain in extremity, Pyrexia
Clinical narrative: dizzy; weak; same day- moderate arm pain radiating to chest and back/Next day- 5:30 am awakened by severe arm/back/chest pain; twitching; eye/headache; eye/headache; high fever; sweating; nausea/diarrhea; nausea/diarrhea; swollen glands; sore throat; whole body ache; same day- moderate arm pain radiating to chest and back/Next day- 5:30 am awakened by severe arm/back/chest pain; same day- moderate arm pain radiating to chest and back/Next day- 5:30 am awakened by severe arm/back/chest pain; This is a spontaneous report from a contactable consumer (patient). A 30-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Er8731), dose 2 via an unspecified route of administration, administered in Arm Right on 25Apr2021 at 11:15 (at the age of 30-years-old) as dose 2, single for covid-19 immunisation. Medical history included allergic to cherries. Concomitant medication included minocycline. The patient previously took bnt162b2 (Batch/Lot Number: Ew0150) as first dose on 04Apr2021 at 11:15 (at the age of 30-years-old) for covid-19 immunisation and experienced Arm pain and severe headache; ceclor and experienced allergy. On 25Apr2021, the patient experienced "same day- moderate arm pain radiating to chest and back/next day- 5:30 am awakened by severe arm/back/chest pain, on 26Apr2021 at 05:30 same day- moderate arm pain radiating to chest and back/next day- 5:30 am awakened by severe arm/back/chest pain (back pain), twitching, eye/headache, high fever, sweating, nausea/diarrhea, swollen glands, sore throat, whole body ache and dizzy on 28Apr2021, weak on 28Apr2021. other vaccine same date vaccine date was provided as 25Apr2021. Facility type vaccine was military base. The patient received no other vaccine in four weeks. Treatment was provided for the events. The patient was not COVID prior vaccination and did not test for COVID post vaccination. Outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Herpes zoster, Pain
Clinical narrative: Developed herpes zoster within 5 days of 1st Covid vaccine injection and developed herpes zoster within 24 hours after 2nd injection. The 1st infection had completely cleared before the 2nd infection; 2nd infection is much more painful; blisters/patches are larger; This is a spontaneous report from a contactable Nurse. This 52-year-old female Nurse (patient) reported for herself that:  A 52-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 23Apr2021 12:15 as DOSE 1, SINGLE, received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 23Apr2021 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included hashimoto's thyroiditis, latex. The patient's concomitant medications were not reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. On 24Apr2021 12:00, the patient experienced developed herpes zoster within 5 days of 1st covid vaccine injection and developed herpes zoster within 24 hours after 2nd injection. the 1st infection had completely cleared before the 2nd infection, 2nd infection is much more painful, blisters/patches are larger. Therapeutic measures were taken as a result of developed herpes zoster within 5 days of 1st covid vaccine injection and developed herpes zoster within 24 hours after 2nd injection. the 1st infection had completely cleared before the 2nd infection, 2nd infection is much more painful, blisters/patches are larger. Events resulted in doctor or other healthcare professional office/clinic visit/physician office visit. The clinical outcome of events were not recovered.    No Follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Herpes zoster, Sensitive skin
Clinical narrative: I have come down with Shingles.; Extremely painful back pain; skin sensitivity; This is a spontaneous report from a contactable Consumer. This 49-Year-old male Consumer (patient) reported. A 49-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: ER2613), dose 2 via an unspecified route of administration, administered in Arm Right on 30Mar2021 14:30 (at the age of 49-years-old) as a single dose for covid-19 immunization. Medical history included herpes zoster from 2010 to an unknown date. Concomitant medication(s) included valsartan; simvastatin; alprazolam. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EN6199), dose 1 via an unspecified route of administration, administered in Arm Right on 11Mar2021 14:30 (at the age of 49-years-old) as a single dose for covid-19 immunization. The patient did not have any allergies. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 15Apr2021, the patient experienced Shingles. Extremely painful back pain and skin sensitivity. AE resulted in doctor or other health care professional office/clinic visit. The patient recevied treatment with valtrex for 1 week. Outcome of the event was not recovered. No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Reactivation of thoracic shingles-just mild so far; This is a spontaneous report from a contactable consumer (Patient). A 59-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot Number: 59267-1000-01), dose 1 via an unspecified route of administration, administered in left arm on 21Apr2021 at 14:45 (at the age of 59-years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included valaciclovir hydrochloride (on hand for whenever there was a recurrence, so patient was taking it) (VALACYCLOVIR HCL) and loratadine (for seasonal allergies) (ALAVERT) taken for seasonal allergy, start and stop date were not reported received in two weeks. The patient previously took sulfa [sulfanilamide] (Known allergies: Rash with sulfa) and experienced rash, shingrix for immunization (did have the full course of the Shingrix vaccine in the past year). The patient was not pregnant at the time of vaccination. No COVID prior vaccination. Facility type vaccine at pharmacy or drug store. On 25Apr2021 at 07:00, the patient experienced reactivation of thoracic shingles-just mild so far. Adverse event treatment include Valacyclovir. No COVID tested post vaccination. The outcome of the event was unknown.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Paraesthesia, X-ray treatment
Clinical narrative: About a week after my shot I started experiencing a tingling in the middle of my back, it comes and goes, worse when I sit down, I went to ER after it didn't get any better a week later; This is a spontaneous report from a contactable consumer (patient himself). A 45-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 10Apr2021 12:45 (age at vaccination: 45 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included none. Concomitant medication(s) included lysine, multivitamin and allergy and acid reducer. The patient had no known allergies. The patient received vaccine in a pharmacy. The patient had no other vaccine in four weeks. On 16Apr2021 12:00, the patient about a week after his shot started experiencing a tingling in the middle of my back, it comes and goes, worse when he sits down. He went to emergency room after it didn't get any better a week later. The patient received Muscle relaxers and ibuprofen as treatment for the adverse event. The patient was worried and was not going to take second shot. On an unknown date, the patient underwent computerised tomogram and x-ray treatment with unknown results. It was unknown if patient had covid before vaccination nor was tested since vaccination. The outcome of the event was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Herpes zoster, Myalgia, Nausea, Pain in extremity
Clinical narrative: Had a little fatigue; Vague nausea that came in a couple of waves; Sore arm and sore muscles; Sore arm and sore muscles; Shingles; This is a spontaneous report from contactable other health care professional (patient). An 88-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: not reported, expiration date: not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. Medical history included shingles, ongoing postherpetic neuralgia, non-hodgkin's lymphoma, chemotherapy, anemic. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 on an unspecified date as SINGLE for covid-19 immunization. On an unspecified date, patient stated Had a little fatigue, vague nausea that came in a couple of waves, sore arm and sore muscles (Painful arm) and (Muscle soreness), Shingles. Patient also stated she had a Shingles shot 5 years ago and had shingles 10 days after. She mentioned that she is still suffering from postherpetic neuralgia because of it and was advised not to get a shingles shot again. I am no longer anemic and have no other hematology issues. Patient mentioned that she got her second dose of vaccine about a week ago. She disconnected from the line while on hold but she experienced some little fatigue, a vague nausea which came in a couple of waves. She mentioned that she had a sore arm and some sore muscles for about two days and she mentions that she was okay right after that. The outcome of events was unknown.  Follow up(30Apr2021): New follow up information received from contactable nurse (patient) included: event information, relevant history information,   No follow-up attempts are needed, no further information expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Chest pain, Conjunctivitis, Dizziness, Dyspnoea
Clinical narrative: A rash on neck and chest; Shortness of breath; Swelling of left hand and arm; Fever of 100.7; Dizziness; Tiredness; Injection site pain; Boil on inner thigh; Headache; chest hurts; pink eye; muscle pain; Pressure in ears; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 50-years-old non pregnant female patient received first dose of bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE,Solution for injection, Lot number-Not reported), via an unspecified route of administration, administered in Arm Left on 29Apr2021 13:45 (age at vaccination 50 years) as DOSE 1, SINGLE for covid-19 immunisation . Medical history included systemic lupus erythematosus, diabetes mellitus, endometriosis , Penicillin, pork, onions, nickel, latex allergy  from an unknown date and unknown if ongoing. Concomitant medication included duloxetine hydrochloride (CYMBALTA). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 29Apr2021 14:45,patient experienced a rash on neck and chest, chest hurts, shortness of breath, swelling of left hand and arm, fever of 100.7, pressure in ears, dizziness, tiredness, pink eye, injection site pain, muscle pain. boil on inner thigh, headache. The reporter assessed the events as non-serious. The patient underwent lab tests and procedures which included body temperature increased: 100.7 on 29Apr2021.Patient did not receive any treatment for the adverse events. The outcome of all events was not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Fatigue, Furuncle, Headache, Myalgia
Clinical narrative: A rash on neck and chest; Shortness of breath; Swelling of left hand and arm; Fever of 100.7; Dizziness; Tiredness; Injection site pain; Boil on inner thigh; Headache; chest hurts; pink eye; muscle pain; Pressure in ears; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 50-years-old non pregnant female patient received first dose of bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE,Solution for injection, Lot number-Not reported), via an unspecified route of administration, administered in Arm Left on 29Apr2021 13:45 (age at vaccination 50 years) as DOSE 1, SINGLE for covid-19 immunisation . Medical history included systemic lupus erythematosus, diabetes mellitus, endometriosis , Penicillin, pork, onions, nickel, latex allergy  from an unknown date and unknown if ongoing. Concomitant medication included duloxetine hydrochloride (CYMBALTA). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 29Apr2021 14:45,patient experienced a rash on neck and chest, chest hurts, shortness of breath, swelling of left hand and arm, fever of 100.7, pressure in ears, dizziness, tiredness, pink eye, injection site pain, muscle pain. boil on inner thigh, headache. The reporter assessed the events as non-serious. The patient underwent lab tests and procedures which included body temperature increased: 100.7 on 29Apr2021.Patient did not receive any treatment for the adverse events. The outcome of all events was not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Rash, Vaccination site pain
Clinical narrative: A rash on neck and chest; Shortness of breath; Swelling of left hand and arm; Fever of 100.7; Dizziness; Tiredness; Injection site pain; Boil on inner thigh; Headache; chest hurts; pink eye; muscle pain; Pressure in ears; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 50-years-old non pregnant female patient received first dose of bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE,Solution for injection, Lot number-Not reported), via an unspecified route of administration, administered in Arm Left on 29Apr2021 13:45 (age at vaccination 50 years) as DOSE 1, SINGLE for covid-19 immunisation . Medical history included systemic lupus erythematosus, diabetes mellitus, endometriosis , Penicillin, pork, onions, nickel, latex allergy  from an unknown date and unknown if ongoing. Concomitant medication included duloxetine hydrochloride (CYMBALTA). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 29Apr2021 14:45,patient experienced a rash on neck and chest, chest hurts, shortness of breath, swelling of left hand and arm, fever of 100.7, pressure in ears, dizziness, tiredness, pink eye, injection site pain, muscle pain. boil on inner thigh, headache. The reporter assessed the events as non-serious. The patient underwent lab tests and procedures which included body temperature increased: 100.7 on 29Apr2021.Patient did not receive any treatment for the adverse events. The outcome of all events was not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Herpes zoster, Hypoaesthesia, Muscle spasms, Pain
Clinical narrative: 5 days after the vaccine I developed shingles.; pain; numbness; rash; The pain has changed over the 3 weeks and this past week it was centralized to my lower back and lower pelvic area; The pain has changed over the 3 weeks and this past week it was centralized to my lower back and lower pelvic area; as in it felt like my ovaries or other parts down there were cramping and being stomped on; This is a spontaneous report from a contactable consumer (patient). A 61-year-old non-pregnant female patient received first dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: unknown), via an unspecified route in the left arm on 03Apr2021 at 10:30 (age at vaccination: 61-year-old), as a single dose for covid-19 immunization. Medical history included HBP, cholesterol and thyroid. Known allergies with one cholesterol medication, patient cant remember the name. The patient concomitant medications were not reported. Historical vaccine included first shingles vaccine in 2018 (Shingrix) and did not get the 2nd shot. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. On 08Apr2021, 5 days after the vaccine, patient developed shingles. It has been over 3 weeks and patient still have pain, numbness, rash is pretty much gone. Patient was still taking pain medication. In Apr2021, the pain has changed over the 3 weeks and this past week it was centralized to her lower back and lower pelvic area, as in it felt like her ovaries or other parts down there were cramping and being stomped on. Patient no longer have a monthly cycle. Patient know of a few others who have experienced shingles or female issues directly after the Pfizer vaccine. Patient was just reporting this as it has been 23 days and she would have held off of the vaccine if she had known this was a possible side effect until more long-term information had been gathered. She was in the minority she was sure, but she knows in her case this was directly related to the vaccine. Adverse events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Therapeutic measures taken as a result of the events included pain medicine. The clinical outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pelvic pain, Rash
Clinical narrative: 5 days after the vaccine I developed shingles.; pain; numbness; rash; The pain has changed over the 3 weeks and this past week it was centralized to my lower back and lower pelvic area; The pain has changed over the 3 weeks and this past week it was centralized to my lower back and lower pelvic area; as in it felt like my ovaries or other parts down there were cramping and being stomped on; This is a spontaneous report from a contactable consumer (patient). A 61-year-old non-pregnant female patient received first dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: unknown), via an unspecified route in the left arm on 03Apr2021 at 10:30 (age at vaccination: 61-year-old), as a single dose for covid-19 immunization. Medical history included HBP, cholesterol and thyroid. Known allergies with one cholesterol medication, patient cant remember the name. The patient concomitant medications were not reported. Historical vaccine included first shingles vaccine in 2018 (Shingrix) and did not get the 2nd shot. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. On 08Apr2021, 5 days after the vaccine, patient developed shingles. It has been over 3 weeks and patient still have pain, numbness, rash is pretty much gone. Patient was still taking pain medication. In Apr2021, the pain has changed over the 3 weeks and this past week it was centralized to her lower back and lower pelvic area, as in it felt like her ovaries or other parts down there were cramping and being stomped on. Patient no longer have a monthly cycle. Patient know of a few others who have experienced shingles or female issues directly after the Pfizer vaccine. Patient was just reporting this as it has been 23 days and she would have held off of the vaccine if she had known this was a possible side effect until more long-term information had been gathered. She was in the minority she was sure, but she knows in her case this was directly related to the vaccine. Adverse events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Therapeutic measures taken as a result of the events included pain medicine. The clinical outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: 5 days after the vaccine I developed shingles.; pain; numbness; rash; The pain has changed over the 3 weeks and this past week it was centralized to my lower back and lower pelvic area; The pain has changed over the 3 weeks and this past week it was centralized to my lower back and lower pelvic area; as in it felt like my ovaries or other parts down there were cramping and being stomped on; This is a spontaneous report from a contactable consumer (patient). A 61-year-old non-pregnant female patient received first dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: unknown), via an unspecified route in the left arm on 03Apr2021 at 10:30 (age at vaccination: 61-year-old), as a single dose for covid-19 immunization. Medical history included HBP, cholesterol and thyroid. Known allergies with one cholesterol medication, patient cant remember the name. The patient concomitant medications were not reported. Historical vaccine included first shingles vaccine in 2018 (Shingrix) and did not get the 2nd shot. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. On 08Apr2021, 5 days after the vaccine, patient developed shingles. It has been over 3 weeks and patient still have pain, numbness, rash is pretty much gone. Patient was still taking pain medication. In Apr2021, the pain has changed over the 3 weeks and this past week it was centralized to her lower back and lower pelvic area, as in it felt like her ovaries or other parts down there were cramping and being stomped on. Patient no longer have a monthly cycle. Patient know of a few others who have experienced shingles or female issues directly after the Pfizer vaccine. Patient was just reporting this as it has been 23 days and she would have held off of the vaccine if she had known this was a possible side effect until more long-term information had been gathered. She was in the minority she was sure, but she knows in her case this was directly related to the vaccine. Adverse events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Therapeutic measures taken as a result of the events included pain medicine. The clinical outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient himself). A 46-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in Arm Left on 14Apr2021 12:00 (at age of 46-years-old) as DOSE 2, SINGLE for COVID-19 immunization. Patient's medical history was not reported. Patient had not known allergies. Concomitant medication included cetirizine hydrochloride (ZYRTEC ALLERGY) taken for an unspecified indication. Patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in Arm Left on 24Mar2021 12:00 (at age of 46-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced shingles on 16Apr2021 12:00. Patient did not receive any treatment for adverse event. Patient did COVID test post vaccination (not specified). The outcome of event was not recovered.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.